- Home
- OCGN vs FERA Comparison
OCGN vs FERA Comparison
Compare OCGN & FERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- FERA
- Stock Information
- Founded
- OCGN 2013
- FERA 2024
- Country
- OCGN United States
- FERA Cayman Islands
- Employees
- OCGN N/A
- FERA N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- FERA
- Sector
- OCGN Health Care
- FERA
- Exchange
- OCGN Nasdaq
- FERA Nasdaq
- Market Cap
- OCGN 283.3M
- FERA 317.4M
- IPO Year
- OCGN N/A
- FERA 2025
- Fundamental
- Price
- OCGN $1.09
- FERA $10.17
- Analyst Decision
- OCGN Strong Buy
- FERA
- Analyst Count
- OCGN 3
- FERA 0
- Target Price
- OCGN $6.00
- FERA N/A
- AVG Volume (30 Days)
- OCGN 6.6M
- FERA 4.5K
- Earning Date
- OCGN 08-01-2025
- FERA 01-01-0001
- Dividend Yield
- OCGN N/A
- FERA N/A
- EPS Growth
- OCGN N/A
- FERA N/A
- EPS
- OCGN N/A
- FERA N/A
- Revenue
- OCGN $4,522,000.00
- FERA N/A
- Revenue This Year
- OCGN N/A
- FERA N/A
- Revenue Next Year
- OCGN N/A
- FERA N/A
- P/E Ratio
- OCGN N/A
- FERA N/A
- Revenue Growth
- OCGN N/A
- FERA N/A
- 52 Week Low
- OCGN $0.52
- FERA $10.00
- 52 Week High
- OCGN $1.67
- FERA $10.60
- Technical
- Relative Strength Index (RSI)
- OCGN 54.73
- FERA N/A
- Support Level
- OCGN $0.99
- FERA N/A
- Resistance Level
- OCGN $1.18
- FERA N/A
- Average True Range (ATR)
- OCGN 0.08
- FERA 0.00
- MACD
- OCGN 0.00
- FERA 0.00
- Stochastic Oscillator
- OCGN 54.55
- FERA 0.00
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About FERA Fifth Era Acquisition Corp I Class A Ordinary Shares
Fifth Era Acquisition Corp I is a blank check company.